Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01156987 · ClinicalTrials.gov registry record · NA

Improved Breast MRI With SWIFT

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT01156987 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01156987, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

Today's medical imaging methods have insufficient specificity for reliable differentiation between benign and malignant breast lesions in patients. Pathologic evaluation is currently the only way to obtain a definitive diagnosis. This research will use a novel method of magnetic resonance imaging (MRI), Sweep Imaging with Fourier Transform (SWIFT), at a very high magnetic field (4 Tesla) to distinguish malignant from benign breast lesions. This research will reveal whether the SWIFT sequence bears new capabilities in medical imaging for breast cancer diagnosis.

Interventions

  • DEVICE Magnetic resonance imaging

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2009-08
Est. Completion 2015-08
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT01156987

The ClinicalTrials.gov registry entry for NCT01156987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Magnetic resonance imaging is the first listed.

NCT01156987 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01156987 about?

NCT01156987 is a clinical study titled "Improved Breast MRI With SWIFT". Today's medical imaging methods have insufficient specificity for reliable differentiation between benign and malignant breast lesions in patients. Pathologic evaluation is currently the only way to obtain a definitive diagnosis. This research will use a novel method of magnetic resonance imaging (M...

What is the current status of trial NCT01156987?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2009-08. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01156987?

The interventions under investigation include: Magnetic resonance imaging (DEVICE).

Who is sponsoring clinical trial NCT01156987?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.